BSF Enterprise PLC Interim Financial Statements (5055Q)
29 Junho 2022 - 3:00AM
UK Regulatory
TIDMBSFA
RNS Number : 5055Q
BSF Enterprise PLC
29 June 2022
29 June 2022
BSF Enterprise PLC
Interim Financial Statements
The Board of BSF Enterprise PLC is pleased to announce its
Unaudited Interim Financial Statements for the six months ended 31
March 2022, which are available on the Company's website:
www.bsfenterprise.com.
As required under Listing Rule 9.6.1 R, these have been
submitted to the National Storage Mechanism and will shortly be
available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further enquiries, please visit www.bsfenterprise.com or
contact:
BSF Enterprise PLC Via SEC Newgate
below
Geoff Baker - Non-Executive Director
Graham Duncan - Chief Financial
Officer
Shard Capital (Broker)
Damon Heath
Erik Woolgar 020 7186 9952
SEC Newgate (Financial Communications)
Bob Huxford 020 3757 6882
Elisabeth Cowell BSF@secnewgate.co.uk
George Esmond
Notes to Editors
BSF Enterprise PLC (BSF) is focused on unlocking the next
generation of biotechnological solutions - using cell-based tissue
engineering to help generate cultured meat, lab-grown leather, as
well as human corneas, collagen growth and skin substitutes, as
part of a radical transformation to deliver sustainable solutions
across a variety of sectors.
It owns 100% of 3D Bio Tissues (3DBT), a tissue engineering with
patent-protected IP that is already producing human corneas to help
restore vision to millions of people. Building on this success, it
aims to produce the UK's first high quality lab-grown meat from its
laboratory in Newcastle the next 12 months, transforming the
meat-production industry towards an ethical and sustainable
practice.
BSF aims to deliver growth to shareholders through the continued
commercialisation of 3DBT's IP, which has multiple applications, as
well as through M&A. It aims to acquire a suite of technologies
that underpins the development of tissue templating for corneas,
meat and leather, and license out the IP to manufacturers,
wholesalers and distributors to help manufacture the products at
scale.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DOCBXGDLGGDDGDI
(END) Dow Jones Newswires
June 29, 2022 02:00 ET (06:00 GMT)
Bsf Enterprise (LSE:BSFA)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Bsf Enterprise (LSE:BSFA)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
